“…In Africa, IMP enzymes had been in Egypt (Masoud et al, 2021;Benmahmod et al, 2019;Abbas et al, 2019), Morocco (Barguigua et al, 2013), Tunisia (Chouchani et al, 2011;Dziri et al, 2020), Tanzania (Mushi et al, 2014) and Sudan (Adam and Elhag, 2018). In Burkina Faso, most of the studies were much focused on ESBLproducing Enterobacteriaceae which occurs resistant to beta-lactam (Metuor Dabire et al, 2013;Metuor et al, 2019a;Metuor Dabire et al, 2019b;Tiemtore et al, 2022) at the expense of carbapenemases, mainly MBL despite the threat they represent for heath care. Nevertheless, previous studies (Sanou et al, 2020;Dembele et al, 2021;Kabore et al, 2022Kabore et al, , 2023 have reported resistance to carbapenems in GNB by the production of carbapenemases.…”